Skip to main content
Top

Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

Abstract

From fingerstick blood glucose monitoring and mechanical insulin pens in the 1970s to modern automated insulin delivery systems, rapidly progressing advances in diabetes technology are transforming management options for people with diabetes, particularly those with type 1 diabetes but also, increasingly, people with type 2 diabetes. However, access to life-changing diabetes technologies is neither uniform nor universally covered, and there is no one size fits all approach. In this position statement, we emphasise to healthcare professionals the importance of supporting individuals with diabetes to access and use the right diabetes technology according to personal needs, capabilities and preferences. In doing so, we highlight the equal importance of avoiding disparities in the provision of diabetes technology by challenging preconceived barriers, which can be overcome with education and determination. We also make a series of suggestions for action to advance the more widespread adoption of diabetes technology while minimising the ‘digital divide’.
Title
Challenges in and opportunities for individualising diabetes technology: a position statement by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group
Authors
Daniela Bruttomesso
John R. Petrie
Mark Evans
G. Alexander Fleming
Helene Hanaire
Reinhard W. Holl
Jennifer L. Sherr
Richard M. Bergenstal
Lutz Heinemann
Anne L. Peters
Publication date
12-03-2026
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-025-06651-9
This content is only visible if you are logged in and have the appropriate permissions.

Raising the standard: ensuring patient safety through minimum requirements for CGM performance

Prof. Chantal Mathieu highlights how the absence of rigorous performance standards for continuous glucose monitors in Europe contributes to wide variability in device accuracy, raising important concerns about patient safety.

Supported by:
  • Abbott Diabetes Care
Prof. Chantal Mathieu
Watch now
Video
Image Credits
Papercut megaphones and a red and blue joined speech bubble/© MirageC / Moment / Getty Images, Woman monitoring glucose level with sensor and an app on her phone while training at swimming pool/© (M) Goffkein, stock.adobe.com (symbolic image with model)